-
1
-
-
70349513464
-
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin
-
Gazerani P, Pedersen NS, Drewes AM, Arendt-Nielsen L. Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. Br J Dermatol 2009 161 : 737 745.
-
(2009)
Br J Dermatol
, vol.161
, pp. 737-745
-
-
Gazerani, P.1
Pedersen, N.S.2
Drewes, A.M.3
Arendt-Nielsen, L.4
-
2
-
-
29144502961
-
Neuroanatomy and neurophysiology of itch
-
Wallengren J. Neuroanatomy and neurophysiology of itch. Dermatol Ther 2005 18 : 292 303.
-
(2005)
Dermatol Ther
, vol.18
, pp. 292-303
-
-
Wallengren, J.1
-
3
-
-
33846968808
-
Placebo theory and its implications for research and clinical practice: A review of the recent literature
-
Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract 2007 7 : 4 20.
-
(2007)
Pain Pract
, vol.7
, pp. 4-20
-
-
Koshi, E.B.1
Short, C.A.2
-
4
-
-
34548079060
-
Successful treatment of notalgia paresthetica with botulinum toxin type A
-
Weinfeld PK. Successful treatment of notalgia paresthetica with botulinum toxin type A. Arch Dermatol 2007 143 : 980 982.
-
(2007)
Arch Dermatol
, vol.143
, pp. 980-982
-
-
Weinfeld, P.K.1
-
5
-
-
0036553463
-
Botulinum toxin type A injection in the treatment of lichen simplex: An open pilot study
-
Heckmann M, Heyer G, Brunner B, Plewig G. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol 2002 46 : 617 619.
-
(2002)
J Am Acad Dermatol
, vol.46
, pp. 617-619
-
-
Heckmann, M.1
Heyer, G.2
Brunner, B.3
Plewig, G.4
-
6
-
-
63049130988
-
Severe post-herpetic neuralgia successfully treated with botulinum toxin A: Three case reports
-
Sotiriou E, Apalla Z, Panagiotidou D, Ioannidis D. Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports. Acta Derm Venereol (Stockh) 2009 89 : 214 215.
-
(2009)
Acta Derm Venereol (Stockh)
, vol.89
, pp. 214-215
-
-
Sotiriou, E.1
Apalla, Z.2
Panagiotidou, D.3
Ioannidis, D.4
-
7
-
-
67549127798
-
Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial
-
Yuan RY, Sheu JJ, Yu JM et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009 72 : 1473 1478.
-
(2009)
Neurology
, vol.72
, pp. 1473-1478
-
-
Yuan, R.Y.1
Sheu, J.J.2
Yu, J.M.3
-
8
-
-
0037322405
-
Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin
-
Krämer HH, Angerer C, Erbguth F et al. Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J Neurol 2003 250 : 188 193.
-
(2003)
J Neurol
, vol.250
, pp. 188-193
-
-
Krämer, H.H.1
Angerer, C.2
Erbguth, F.3
-
9
-
-
34249742661
-
Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin
-
Tugnoli V, Capone JG, Eleopra R et al. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. Pain 2007 130 : 76 83.
-
(2007)
Pain
, vol.130
, pp. 76-83
-
-
Tugnoli, V.1
Capone, J.G.2
Eleopra, R.3
-
10
-
-
58149157911
-
Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
-
Gazerani P, Pedersen NS, Staahl C et al. Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain 2009 141 : 60 9.
-
(2009)
Pain
, vol.141
, pp. 60-9
-
-
Gazerani, P.1
Pedersen, N.S.2
Staahl, C.3
-
11
-
-
0034792766
-
Cutaneous field stimulation (CFS) in treatment of severe localized itch
-
Wallengren J, Sundler F. Cutaneous field stimulation (CFS) in treatment of severe localized itch. Arch Dermatol 2001 137 : 1323 1325.
-
(2001)
Arch Dermatol
, vol.137
, pp. 1323-1325
-
-
Wallengren, J.1
Sundler, F.2
|